Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma
This study is currently recruiting participants.
Verified September 2013 by Spectrum Health Hospitals
Van Andel Research Institute
Archer Biosciences, Inc.
Information provided by (Responsible Party):
Giselle Sholler, Spectrum Health Hospitals
First received: November 28, 2011
Last updated: September 11, 2013
Last verified: September 2013
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||November 2018|
|Estimated Primary Completion Date:||November 2014 (Final data collection date for primary outcome measure)|